DrugPatentWatch Database Preview
Email this page to a colleague
« Back to Dashboard
Pf-04531083 is an investigational drug.
There have been 6 clinical trials for Pf-04531083. The most recent clinical trial was a Phase 1 trial, which was initiated on October 1st 2011.
The most common disease conditions in clinical trials are Chronic Pain, Toothache, and [disabled in preview]. The leading clinical trial sponsors are Pfizer and [disabled in preview].
Recent Clinical Trials for Pf-04531083
|Efficacy Of Pf-04531083 In Treating Post-Surgical Dental Pain||Pfizer||Phase 2|
|Study To Assess The Effect Of PF-04531083 On Heat Pain In Healthy Volunteers With Ultraviolet Light Sensitized Skin||Pfizer||Phase 1|
|A Study To Observe The Performance Of A Tablet Form Of PF-04531083 As Evidenced By The Concentration Of PF-04531083 In The Blood With Time Following Oral Administration To Healthy Volunteers.||Pfizer||Phase 1|